The Discounted Cash Flow (DCF) valuation of Celldex Therapeutics Inc (CLDX) is (60.19) USD. With the latest stock price at 25.41 USD, the upside of Celldex Therapeutics Inc based on DCF is -336.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 8.1% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (186.35) - (36.73) | (60.19) |
| Upside | -833.4% - -244.5% | -336.9% |